Production (Stage)
Kewaunee Scientific Corporation
KEQU
$58.45
-$0.69-1.17%
NASDAQ
| 04/30/2025 | 01/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 14.86% | 40.62% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 14.86% | 40.62% | |||
| Cost of Revenue | 8.86% | 44.29% | |||
| Gross Profit | 30.79% | 31.73% | |||
| SG&A Expenses | -3.66% | 69.46% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.75% | 49.82% | |||
| Operating Income | 277.78% | -49.26% | |||
| Income Before Tax | 460.71% | -67.57% | |||
| Income Tax Expenses | 2,138.89% | -111.79% | |||
| Earnings from Continuing Operations | 257.70% | -54.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -234.48% | -314.29% | |||
| Net Income | 258.20% | -54.99% | |||
| EBIT | 277.78% | -49.26% | |||
| EBITDA | 156.91% | -27.23% | |||
| EPS Basic | 260.50% | -54.99% | |||
| Normalized Basic EPS | 472.77% | -68.65% | |||
| EPS Diluted | 261.98% | -55.45% | |||
| Normalized Diluted EPS | 471.88% | -68.88% | |||
| Average Basic Shares Outstanding | -0.63% | 0.00% | |||
| Average Diluted Shares Outstanding | -0.47% | 0.71% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||